China Universal Asset Management Company’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
China Universal Asset Management Company's AXSM Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Axsome Therapeutics (AXSM) stake by 9.8% in Q2 2026, selling an estimated $193K and leaving 8,190 shares worth $2M. The position accounts for 0.12% of the portfolio, ranked #133.
China Universal Asset Management Company first reported a position in AXSM in Q3 2022 and has held it in 16 quarters since. 328 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.
- China Universal Asset Management Company held 8,190 shares of Axsome Therapeutics worth $2M as of Q2 2026.
- China Universal Asset Management Company sold 888 Axsome Therapeutics shares in Q2 2026, an estimated $193K.
- Axsome Therapeutics made up 0.12% of China Universal Asset Management Company's portfolio in Q2 2026, its #133 holding.
- China Universal Asset Management Company first reported a position in Axsome Therapeutics in Q3 2022 and has held it in 16 quarters since.
- 328 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.